Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: bivalent typhoid vaccine - Novartis Vaccines Institute for Global Health

Next Previous
Search
Drug Profile

Research programme: bivalent typhoid vaccine - Novartis Vaccines Institute for Global Health

Alternative Names: Bivalent Salmonella typhi/Salmonella paratyphi vaccine - NVGH; Bivalent typhoid vaccine - Novartis; Combined typhoid-paratyphoid vaccine - Novartis; Dual-acting typhoid vaccine - Novartis; Salmonella bivalent typhi/paratyphi A vaccine - NVGH

Latest Information Update: 16 Jul 2016

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novartis Vaccines Institute for Global Health
  • Class Bacterial vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Typhoid

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for research development in Typhoid(Prevention) in Italy (Parenteral)
  • 08 Jul 2013 Novartis' typhoid vaccines (Vi-CRM197 and the bivalent typhoid-parathyroid vaccine) is licensed to Biological E Ltd worldwide, excluding developed countries

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top